David Shaw’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.54M Sell
68,533
-75,611
-52% -$1.97M ﹤0.01% 3419
2026
Q1
$3.94M Sell
144,144
-334,488
-70% -$11.9M ﹤0.01% 2362
2025
Q4
$19.9M Buy
478,632
+376,136
+367% +$15.3M 0.01% 1246
2025
Q3
$4.73M Buy
+102,496
New +$5.47M ﹤0.01% 2262
2025
Q2
Sell
-74,714
Closed -$3.95M 4399
2025
Q1
$4.16M Buy
+74,714
New +$3.58M ﹤0.01% 2030
2024
Q3
Sell
-3,302
Closed -$221K 4582
2024
Q2
$209K Buy
+3,302
New +$198K ﹤0.01% 4056
2023
Q4
Sell
-137,402
Closed -$12M 4353
2023
Q3
$11M Buy
137,402
+48,648
+55% +$3.82M 0.01% 1234
2023
Q2
$7.17M Buy
88,754
+79,307
+839% +$7.42M 0.01% 1616
2023
Q1
$1.15M Sell
9,447
-5,999
-39% -$815K ﹤0.01% 3072
2022
Q4
$2.06M Sell
15,446
-15,436
-50% -$1.88M ﹤0.01% 2921
2022
Q3
$3.45M Buy
30,882
+19,665
+175% +$2.52M ﹤0.01% 2475
2022
Q2
$1.52M Sell
11,217
-2,800
-20% -$421K ﹤0.01% 3311
2022
Q1
$2.33M Sell
14,017
-16,602
-54% -$3.15M ﹤0.01% 3158
2021
Q4
$5.47M Buy
30,619
+25,024
+447% +$4.47M ﹤0.01% 2272
2021
Q3
$990K Buy
+5,595
New +$927K ﹤0.01% 3602

Other funds holding CNXC

David Shaw's CNXC Position: Q2 2026 in Review

David Shaw reduced its Concentrix (CNXC) stake by 52% in Q2 2026, selling an estimated $1.97M and leaving 68,533 shares worth $1.54M. The position accounts for ﹤0.01% of the portfolio, ranked #3419.

David Shaw first reported a position in CNXC in Q3 2021 and has held it in 15 quarters since. The position peaked at $19.9M in Q4 2025. 269 funds tracked by Wall St. Rank hold CNXC as of Q2 2026.

  • David Shaw held 68,533 shares of Concentrix worth $1.54M as of Q2 2026.
  • David Shaw sold 75,611 Concentrix shares in Q2 2026, an estimated $1.97M.
  • Concentrix made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #3419 holding.
  • David Shaw first reported a position in Concentrix in Q3 2021 and has held it in 15 quarters since.
  • David Shaw's Concentrix position peaked at $19.9M in Q4 2025.
  • 269 funds tracked by Wall St. Rank held Concentrix as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.